Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
about
Genetic and epigenetic alterations in pancreatic carcinogenesisThe MUC gene family: their role in diagnosis and early detection of pancreatic cancerIntraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant TherapyPancreatic adenocarcinoma pathology: changing "landscape"Concomitant pancreatic endocrine neoplasm and intraductal papillary mucinous neoplasm: a case report and literature reviewInsights into the Pathogenesis of Pancreatic Cystic Neoplasms.Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade.Pathology and molecular genetics of pancreatic neoplasms.Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic ChemotherapyMolecular analysis of pancreatic acinar cell cystadenomas: Evidence of a non-neoplastic nature.Precursor lesions of pancreatic cancer.In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.EZH2 is associated with malignant behavior in pancreatic IPMN via p27Kip1 downregulation.Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2.Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway.Intraductal papillary mucinous neoplasm of the pancreas: an updateCirculating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancerGene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas.Genomic landscapes of pancreatic neoplasia.PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinomaMolecular mechanisms of pancreatic cancer and potential targets of treatment.Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.Carcinogenesis of pancreatic adenocarcinoma: precursor lesions.PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.Pancreatic cysts: preoperative diagnosis and clinical management.Intraductal oncocytic papillary neoplasms of the pancreas and bile ducts: a description of five new cases and review based on a systematic survey of the literature.Molecular analysis of cyst fluid aspiration in the diagnosis and risk assessment of cystic lesions of the pancreas.Pancreatic cancer genomes: toward molecular subtyping and novel approaches to diagnosis and therapy.A review of pancreatic cyst fluid analysis in the differential diagnosis of pancreatic cyst lesions.SMAD4 and its role in pancreatic cancer.The genetic classification of pancreatic neoplasia.Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.Novel Biomarkers for Pancreatic Cysts.Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas.The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.Intraductal papillary-mucinous neoplasia of the pancreas: Histopathology and molecular biologyDistinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
P2860
Q24598655-EE31264D-AA16-4547-A5C9-9B4E78582888Q24800242-B25085C1-D8BE-4723-B91C-8EFFC1E0194AQ26796495-6A71C118-7203-46BF-8940-8D36E6A3AAE8Q26799446-CBE2E604-9CA5-497C-92EB-6F03907F6617Q26852943-8FB34253-198F-4DB7-80C5-6B554AB355E4Q30234478-76A83AD9-48A8-4F75-B6E0-C37E52B92EC2Q33280569-B684B859-2E30-4246-A9F8-E51E0F64CDEFQ33581119-B77CA08D-2F4B-40E3-8236-25007A885E09Q33754040-594C96E8-6B8C-4AC1-9D98-0E3C70DEEDAFQ33755454-CDC3BBF4-7C61-4FD8-9FD7-CD5C4126D818Q33844265-A779275A-7C49-46A7-8AAB-88E48A8A4959Q33855814-85D3CDA8-1FE6-4951-AD00-CF7C676D4238Q33911620-C0ABF3F3-876C-4698-A450-29A53FA1ACA9Q33988909-E9D029D8-47F2-4B72-9C88-5BC54D37BF3CQ34008627-E60762FC-FFF7-4DEF-962F-E754E49EAAC2Q34024222-874B167D-2E1A-412E-A7E5-2ABD0D50B54DQ34347568-3678A3DF-00CE-4158-B3D9-40E7B5B11DE7Q34657866-53298E31-AB25-4B88-A249-854E34C5F829Q34775829-20BFBAEA-DEC9-4981-9ADE-364209F018A8Q35094629-7583E542-431D-460A-A59F-14D25EFE4D60Q35170720-8B643A9D-D639-4C3B-9D6C-EFD54E407D78Q35606891-A91BC39B-D22D-4787-8AB8-58DEA1701E3DQ36395433-F269FE73-9883-48B9-8A28-7D3F642B4CF8Q36758436-D464E50A-230C-4F64-B02A-437E31127BC3Q36849427-3FFCCF77-C1DF-4D5D-8217-3894B6B3C087Q37291172-F704798D-E601-44FF-8047-FB6009483493Q37558625-2D48DC97-AFB0-43FE-8879-38AA30866C7CQ37665389-DD0E63E2-4F55-4F15-98C3-251AEC9FF545Q37750552-6DEEE609-F0C9-4676-9BC9-2ACD27166B6CQ37989233-634DEEBC-DF50-4686-B5F8-7AAC0A64F545Q38113752-4FA6AA7B-0C1F-4194-87EE-37F351DAD3A6Q38149837-8F11F4FD-FAE5-4CFD-85E0-77EDE757E483Q38281261-609EAEC7-88BB-42D3-B4F0-EEB70752A910Q38326191-75E138A7-DFB8-4F80-AD4C-926AB90C07A4Q38646960-1EB175AB-D63E-4FFC-98F5-35F8BD542B50Q38757526-E97DF80C-4E75-455B-A6D4-232F569B0F07Q39628515-4248247E-CF0F-44C7-A425-D9C9E34C831EQ41105157-A5F06B5C-AE8B-4F36-94C1-13851D7BA2E5Q41131015-A08CC0E2-FB8B-4F90-A6CB-7FDA5439F431Q42721594-F56CF06B-78DD-44F1-AA4A-84CDFA51882D
P2860
Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Aberrant p16(INK4A) and DPC4/S ...... nvasive ductal adenocarcinoma.
@ast
Aberrant p16(INK4A) and DPC4/S ...... nvasive ductal adenocarcinoma.
@en
type
label
Aberrant p16(INK4A) and DPC4/S ...... nvasive ductal adenocarcinoma.
@ast
Aberrant p16(INK4A) and DPC4/S ...... nvasive ductal adenocarcinoma.
@en
prefLabel
Aberrant p16(INK4A) and DPC4/S ...... nvasive ductal adenocarcinoma.
@ast
Aberrant p16(INK4A) and DPC4/S ...... nvasive ductal adenocarcinoma.
@en
P2093
P2860
P356
P1433
P1476
Aberrant p16(INK4A) and DPC4/S ...... invasive ductal adenocarcinoma
@en
P2093
A V Biankin
R L Sutherland
R P Eckstein
S A Biankin
S M Henshall
P2860
P304
P356
10.1136/GUT.50.6.861
P407
P577
2002-06-01T00:00:00Z